Faculty profile

Mansoor Husain

ResearcherMedicineUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Mansoor Husain

Researcher

Medicine

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
31 publications in the last five years, latest in 2026.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 8 research grants (8 CIHR), most recently in 2025.
Supervised 4 trainees who won CIHR awards, most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

124

Publications

2,177

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Heart Failure Metabolism Transgenic Mice Mouse Models Of Hypertension Rna-Sequencing Sca1 Stem Cells Animal Models

Latest papers

Relapse in Cardiac Sarcoidosis: Patterns and Predictors on Serial 18F-FDG PET Imaging.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2026
B cells drive CD4 T cell immunosenescence and age-associated health decline.
Science immunology · 2026
Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.
Diabetes, obesity & metabolism · 2025

All 124 publications

Latest funding

Role of mitochondrial trifunctional protein in heart failure
CIHR · 2025 · Nominated PI
$956,250
Examining GLP-1 peptides as a novel cardioprotective agent for pediatric cardiac surgery
CIHR · 2022 · Supervisor
$105,000
Role of vessel-resident progenitor cells in vascular disease
CIHR · 2021 · Nominated PI
$918,000

All 18 grants and awards

124 publications.

Relapse in Cardiac Sarcoidosis: Patterns and Predictors on Serial 18F-FDG PET Imaging.

Gerodias FJ, Godoy LC, Magtibay K, Darabi F, Avery L, Alba C, Birnie DH, Amad H, Husain M, Lee DS, Iwanochko RM

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2026

DOI: 10.1016/j.nuclcard.2026.102962 PMID: 42660489

B cells drive CD4 T cell immunosenescence and age-associated health decline.

Khan S, Chakraborty M, Wu F, Chen N, Wang T, Chan YT, Sayad A, Kotlyar M, Alibhai FJ, Woo M, Li RK, Husain M, Jurisica I, Gehring AJ, Ohashi PS, Furman D, Tsai S, Winer S, Winer DA

Science immunology2026

DOI: 10.1126/sciimmunol.adv7615 PMID: 41616067

Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.

Zhou J, Husain M, Li Y, Liu W, Shen Z, Vilsbøll T, Ge J

Diabetes, obesity & metabolism2025

DOI: 10.1111/dom.16621 PMID: 40704485

Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF.

Sauer AJ, Chang J, Fu Z, Valenzuela Ripoll C, Cho Y, Guo Z, Jones P, Selvaraj S, Windsor SL, Husain M, Inzucchi SE, McGuire DK, Pitt B, Scirica BM, Austin BA, Umpierrez G, Tran S, Dahlbäck B, Javaheri A, Kosiborod MN, DEFINE-HF Investigators

JACC. Advances2025

DOI: 10.1016/j.jacadv.2025.101800 PMID: 40579063

Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HF.

Ambrosy AP, Sauer AJ, Patel S, Windsor SL, Borlaug BA, Husain M, Inzucchi SE, Kitzman DW, McGuire DK, Shah SJ, Sharma K, Umpierrez G, Kosiborod MN

ESC heart failure2025

DOI: 10.1002/ehf2.15184 PMID: 39716939

Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.

Bain SC, Belmar N, Hoff ST, Husain M, Rasmussen S, Vilsbøll T, Petrie MC

Diabetes therapy : research, treatment and education of diabetes and related disorders2025

DOI: 10.1007/s13300-024-01659-7 PMID: 39520501

Real-world effectiveness of early revascularization in stable coronary artery disease with moderate or severe ischemia.

Gerodias FJ, Iwanochko RM, Austin PC, Wang X, Džavík V, Goodman SG, Udell JA, Ouzounian M, Ross HJ, Godoy LC, Amad H, Husain M, Lee DS

American heart journal plus : cardiology research and practice2025

DOI: 10.1016/j.ahjo.2025.100596 PMID: 40948992

Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement

Romeo S, Vidal-Puig A, Husain M, Ahima R, Arca M, Bhatt DL, Diehl AM, Fontana L, Foo R, Frühbeck G

European Heart Journal202585 citations

DOI: 10.1093/eurheartj/ehaf314

Endothelial dysfunction drives atherosclerotic plaque macrophage-dependent abdominal aortic aneurysm formation

Thayaparan D, Emoto T, Khan AB, Besla R, Hamidzada H, El-Maklizi M, Sivasubramaniyam T, Vohra S, Hagerman A, Nejat S

Nature Immunology202541 citations

DOI: 10.1038/s41590-025-02132-8

Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.

Gustafson D, DiStefano PV, Wang XF, Wu R, Ghaffari S, Ching C, Rathnakumar K, Alibhai F, Syonov M, Fitzpatrick J, Boudreau E, Lau C, Galant N, Husain M, Li RK, Lee WL, Parekh RS, Monnier PP, Fish JE

Diabetologia2024

DOI: 10.1007/s00125-024-06120-9 PMID: 38489029

Something wrong or missing on this profile? Suggest a correction

Mansoor Husain

Research

Latest papers

Latest funding

Relapse in Cardiac Sarcoidosis: Patterns and Predictors on Serial 18F-FDG PET Imaging.

B cells drive CD4 T cell immunosenescence and age-associated health decline.

Effect of semaglutide versus placebo on cardiorenal outcomes by prior cardiovascular disease and baseline body mass index: Pooled post hoc analysis of SUSTAIN 6 and PIONEER 6.

Dapagliflozin's Association With Cardiorenal Outcomes and Apolipoprotein M Levels in HFrEF Patients: Insights From DEFINE-HF.

Baseline kidney function and the effects of dapagliflozin on health status in heart failure in DEFINE-HF and PRESERVED-HF.

Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN&#xa0;6 and PIONEER&#xa0;6.

Real-world effectiveness of early revascularization in stable coronary artery disease with moderate or severe ischemia.

Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement

Endothelial dysfunction drives atherosclerotic plaque macrophage-dependent abdominal aortic aneurysm formation

Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes.

Frequent collaborators

Ren-Ke Li

Slava Epelman

Subodh Verma

Anand Kumar

Scott Heximer

Kumaraswamy Nanthakumar

Srinivas Murthy

Marc Carrier

Gordon Keller

Peter Lawrence Gross

Ryan Zarychanski

Francois Lamontagne

Peter Backx

Francois Lamontagne

Igor Jurisica

Filio Billia

Chi-Chung Hui

Francois Lamontagne

Peter Backx

Srinivas Murthy

Anand Kumar

Sue Tsai

Ryan Zarychanski

Gloria Vazquez-Grande

Howard Leong-Poi

Deborah Siegal

Martin R Stampfli

Ralph Dacosta

Peter Zandstra

Filip Konecny

Jean-Eric Tarride

Bernardo Trigatti

Eva Lonn

Michael Heffernan

Sanjit Jolly

Bernard Zinman

Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6.